Rep. Michael J. Zalewski

Filed: 4/23/2018

 

 


 

 


 
10000HB4650ham001LRB100 17477 SLF 38606 a

1
AMENDMENT TO HOUSE BILL 4650

2    AMENDMENT NO. ______. Amend House Bill 4650 on page 1, line
35, by replacing "Section" with "Sections 314.5 and"; and
 
4on page 1, immediately below line 5, by inserting the
5following:
 
6    "(720 ILCS 570/314.5)
7    Sec. 314.5. Medication shopping; pharmacy shopping.
8    (a) It shall be unlawful for any person knowingly or
9intentionally to fraudulently obtain or fraudulently seek to
10obtain any controlled substance or prescription for a
11controlled substance from a prescriber or dispenser while being
12supplied with any controlled substance or prescription for a
13controlled substance by another prescriber or dispenser,
14without disclosing the fact of the existing controlled
15substance or prescription for a controlled substance to the
16prescriber or dispenser from whom the subsequent controlled

 

 

10000HB4650ham001- 2 -LRB100 17477 SLF 38606 a

1substance or prescription for a controlled substance is sought.
2    (b) It shall be unlawful for a person knowingly or
3intentionally to fraudulently obtain or fraudulently seek to
4obtain any controlled substance from a pharmacy while being
5supplied with any controlled substance by another pharmacy,
6without disclosing the fact of the existing controlled
7substance to the pharmacy from which the subsequent controlled
8substance is sought.
9    (c) A person may be in violation of Section 3.23 of the
10Illinois Food, Drug and Cosmetic Act or Section 406 of this Act
11when medication shopping or pharmacy shopping, or both.
12    (c-5) Effective January 1, 2018, each prescriber
13possessing an Illinois controlled substances license shall
14register with the Prescription Monitoring Program. Each
15prescriber or his or her designee shall also document an
16attempt to access patient information in the Prescription
17Monitoring Program to assess patient access to controlled
18substances when providing an initial prescription for Schedule
19II narcotics such as opioids, except for prescriptions for
20oncology treatment or palliative care, or a 7-day or less
21supply provided by a hospital emergency department when
22treating an acute, traumatic medical condition. This attempt to
23access shall be documented in the patient's medical record. The
24hospital shall facilitate the designation of a prescriber's
25designee for the purpose of accessing the Prescription
26Monitoring Program for services provided at the hospital.

 

 

10000HB4650ham001- 3 -LRB100 17477 SLF 38606 a

1    (d) When a person has been identified as having 3 or more
2prescribers or 3 or more pharmacies, or both, that do not
3utilize a common electronic file as specified in Section 20 of
4the Pharmacy Practice Act for controlled substances within the
5course of a continuous 30-day period, the Prescription
6Monitoring Program may issue an unsolicited report to the
7prescribers, dispensers, and their designees informing them of
8the potential medication shopping. If an unsolicited report is
9issued to a prescriber or prescribers, then the report must
10also be sent to the applicable dispensing pharmacy.
11    (e) Nothing in this Section shall be construed to create a
12requirement that any prescriber, dispenser, or pharmacist
13request any patient medication disclosure, report any patient
14activity, or prescribe or refuse to prescribe or dispense any
15medications.
16    (f) This Section shall not be construed to apply to
17inpatients or residents at hospitals or other institutions or
18to institutional pharmacies.
19    (g) Any patient or pharmacist feedback, including grades,
20ratings, or written or verbal statements, in opposition to a
21clinical decision that the prescription of a controlled
22substance is not medically necessary shall not be the basis of
23any adverse action, evaluation, or any other type of negative
24credentialing, contracting, licensure, or employment action
25taken against a prescriber or dispenser.
26(Source: P.A. 99-480, eff. 9-9-15; 100-564, eff. 1-1-18.)"; and
 

 

 

10000HB4650ham001- 4 -LRB100 17477 SLF 38606 a

1by replacing line 23 on page 4 through line 1 on page 5 with the
2following:
 
3"eligibility of a person to be selected as a designee. In this
4subsection (g), "pharmacist" shall include a clinical
5pharmacist employed by and designated by a Medicaid Managed
6Care Organization providing services under Article V of the
7Illinois Public Aid Code under a contract with the Department
8of Health and Family Services for the sole purpose of clinical
9review of services provided to persons covered by the entity
10under the contract to determine compliance with subsections (a)
11and (b) of Section 314.5 of this Act. A managed care entity
12pharmacist shall notify prescribers of review activities.".